Madrigal Pharmaceuticals Inc (MDGL) — Capital Reinvestment Ratio
Madrigal Pharmaceuticals Inc (MDGL) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow ($79.85 Million) in capital expenditures ($857.00K). Check MDGL goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Madrigal Pharmaceuticals Inc Capital Reinvestment Ratio (2007–2007)
This chart tracks Madrigal Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see MDGL cash generation efficiency.
Annual Capital Reinvestment Ratio for Madrigal Pharmaceuticals Inc (2007–2007)
Year-by-year Capital Reinvestment Ratio for Madrigal Pharmaceuticals Inc from 2007 to 2007. See Madrigal Pharmaceuticals Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2007 | 0.09x | $27.22 Million | $2.35 Million | — |